Want to see TSE:AION full AI Analyst Report?
AION Stock Chart & Stats
C$0.01
C$0.00(0.00%)
At close: 4:00 PM EST
C$0.01
C$0.00(0.00%)
Day’s Range― - ―
52-Week Range<C$0.01 - C$0.01
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
C$2.42M
Enterprise ValueC$4.50M
Total Cash (Recent Filing)C$13.82K
Total Debt (Recent Filing)C$2.81M
Price to Earnings (P/E)―
Beta-2.75
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding483,549,260
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-1.37
Price to Sales (P/S)14.43
P/FCF Ratio-6.27
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthAion Therapeutic's significant revenue growth indicates successful market penetration and potential for future expansion in the biotechnology sector.
Product InnovationAion Therapeutic's innovative approach to using natural compounds for therapeutic interventions positions it uniquely in the growing natural medicine market.
Partnership OpportunitiesPotential partnerships with larger firms could enhance distribution and co-development, expanding Aion's market reach and product availability.
Bears Say
High LeverageAion's high leverage and negative equity indicate financial instability, which could limit its ability to invest in growth and innovation.
Operational LossesPersistent operational losses reflect inefficiencies that could hinder long-term profitability and require strategic improvements to achieve financial sustainability.
Cash Flow ChallengesNegative cash flow and reliance on external financing highlight liquidity issues, potentially restricting Aion's operational flexibility and growth investments.
Aion Therapeutic Inc News
AION FAQ
What was Aion Therapeutic Inc’s price range in the past 12 months?
Aion Therapeutic Inc lowest stock price was <C$0.01 and its highest was C$0.01 in the past 12 months.
What is Aion Therapeutic Inc’s market cap?
Aion Therapeutic Inc’s market cap is C$2.42M.
When is Aion Therapeutic Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Aion Therapeutic Inc’s earnings last quarter?
Currently, no data Available
Is Aion Therapeutic Inc overvalued?
According to Wall Street analysts Aion Therapeutic Inc’s price is currently Overvalued.
Does Aion Therapeutic Inc pay dividends?
Aion Therapeutic Inc does not currently pay dividends.
What is Aion Therapeutic Inc’s EPS estimate?
Aion Therapeutic Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Aion Therapeutic Inc have?
Aion Therapeutic Inc has 483,549,260 shares outstanding.
What happened to Aion Therapeutic Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Aion Therapeutic Inc?
Currently, no hedge funds are holding shares in TSE:AION
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Aion Therapeutic Inc
Headquartered in Toronto, Canada, Aion Therapeutic Inc. provides medical cannabis products across the nation. The company, which was established in 2011, formerly operated as Osoyoos Cannabis Inc. until it officially adopted its current name in August 2020.
Technical Analysis
Willow Biosciences Inc
―
Quantum Biopharma
―
MediPharm Labs
―
Avicanna
―
InnoCan Pharma
―